Literature DB >> 15222098

[Cancer incidence in Japan].

Hideaki Tsukuma1, Wakiko Ajiki, Akira Oshima.   

Abstract

Based on the estimates by the Research Group for Population-based Cancer Registration in Japan, time-trend of cancer incidence in Japan was described and analyzed. During the period of 1975-1998, the annual total cancer incidence increased 111,000-290,000 in males, and 96,000-208,000 among females. The higher incidence was prominent for cancers of the colorectum, lung, liver, gallbladder and extrahepatic bill duct (both sexes), prostate, and breast (female), whereas it was low or negligible for cancers of the stomach (both sexes) and uterus. The increased cancer incidence was globally attributed to the rapid growth of the Japanese aged population. However, a remarkable increase in the age-standardized incidence rate was also observed for cancers of the colorectum (both sexes), prostate, and breast (female). A decline in the age-standardized incidence rate was continuously observed for cancer of the stomach and uterus. A birth cohort analysis has revealed that the cancer incidence in Japan has been highly affected by the generation. Based on the Cancer Incidence in Five Continents Vol. VIII, the cumulative risk of cancer incidence (0-79 years old) was calculated and compared among the Japanese population (6 registries' data), US-Japanese and US-white. Several characteristics were suggested and discussed for Japanese cancer risk.

Entities:  

Mesh:

Year:  2004        PMID: 15222098

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN: 0385-0684


  7 in total

Review 1.  Early breast cancer.

Authors:  Tomoyoshi Suzuki; Masakazu Toi; Shigehira Saji; Kazumi Horiguchi; Tomoyuki Aruga; Eiji Suzuki; Shinichiro Horiguchi; Nobuaki Funata; Katsuyuki Karasawa; Noriko Kamata
Journal:  Int J Clin Oncol       Date:  2006-04       Impact factor: 3.402

2.  DPEP1, expressed in the early stages of colon carcinogenesis, affects cancer cell invasiveness.

Authors:  Yuji Toiyama; Yasuhiro Inoue; Hiromi Yasuda; Susumu Saigusa; Takeshi Yokoe; Yoshinaga Okugawa; Koji Tanaka; Chikao Miki; Masato Kusunoki
Journal:  J Gastroenterol       Date:  2010-09-08       Impact factor: 7.527

3.  High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer.

Authors:  E L Wang; Z R Qian; M Nakasono; T Tanahashi; K Yoshimoto; Y Bando; E Kudo; M Shimada; T Sano
Journal:  Br J Cancer       Date:  2010-02-09       Impact factor: 7.640

4.  Overexpression of the S100A2 protein as a prognostic marker for patients with stage II and III colorectal cancer.

Authors:  Taiki Masuda; Toshiaki Ishikawa; Kaoru Mogushi; Satoshi Okazaki; Megumi Ishiguro; Satoru Iida; Hiroshi Mizushima; Hiroshi Tanaka; Hiroyuki Uetake; Kenichi Sugihara
Journal:  Int J Oncol       Date:  2016-01-11       Impact factor: 5.650

5.  Antisense RNA transcripts in the blood may be novel diagnostic markers for colorectal cancer.

Authors:  Tomohiro Kurokawa; Keisuke Kohno; Kentaro Nagai; Mitsuru Chiba; Sugiru Pak; Soichiro Murata; Kiyoshi Fukunaga; Hiroshi Yasue; Nobuhiro Ohkohchi
Journal:  Oncol Lett       Date:  2017-07-15       Impact factor: 2.967

6.  Mitotic centromere-associated kinesin is a novel marker for prognosis and lymph node metastasis in colorectal cancer.

Authors:  K Ishikawa; Y Kamohara; F Tanaka; N Haraguchi; K Mimori; H Inoue; M Mori
Journal:  Br J Cancer       Date:  2008-05-27       Impact factor: 7.640

7.  Trends in lung cancer incidence by histological type in Osaka, Japan.

Authors:  Yasuhiro Toyoda; Tomio Nakayama; Akiko Ioka; Hideaki Tsukuma
Journal:  Jpn J Clin Oncol       Date:  2008-08-09       Impact factor: 3.019

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.